Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

SARS-CoV-2 induces tissue immune memory

A new study reports that the SARS-CoV-2 induces protective tissue memory that includes both humoral and cellular elements to protect specific tissue sites.

14 Oct 2021

COVID-19 immunity in family members reduces risk of infection by 45-97%

An interesting new study examines the risk of COVID-19 to a susceptible individual who is part of a family with COVID-19 immunity.

14 Oct 2021

Mutation of cysteine residues in NRP1 reduces SARS-CoV-2 spike protein entry into cells

Researchers have been investigating altered protein conformations in variants of concern to provide further insight for future therapies against COVID-19.

14 Oct 2021

Improving COVID-19 vaccinations through contact-tracing apps

In our latest interview, News-Medical spoke to Dr. Mark Penney about how we can improve COVID-19 vaccinations through contact-tracing apps.

14 Oct 2021

Study finds relatively low rate of COVID-19 infection following full vaccination in North Carolina

A recent study seeks to investigate the characteristics of individuals with breakthrough infections post-vaccination in North Carolina, USA.

14 Oct 2021

Ondansetron use associated with increased survival in mechanically ventilated COVID-19 patients

A recent study analyzes real-world data using artificial intelligence to provide insights into using ondansetron, an antiemetic agent, among SARS-CoV-2 positive patients.

14 Oct 2021

Methods used to limit transmission of SARS-CoV-2 effective against other viruses in China

Researchers from Shenzhen's Children's Hospital have been investigating the occurrence of these diseases while these measures were in effect to understand better how to curb their transmission.

14 Oct 2021

COVID-19 booster for immunosuppressed patients with inflammatory bowel disease

Researchers have published correspondence detailing the reasoning behind providing a third booster dose to patients with inflammatory bowel disease that have been treated with drugs that can reduce the response to the COVID-19 vaccines.

14 Oct 2021

Developing New Technology for the Encapsulation of mRNA-Based Vaccines in Lipid Nanoparticles (LNPs)

NewsMed speaks to KNAUER about the company’s background, its range of specialisms and its pioneering work to facilitate the largescale production of LNPs while meeting the stringent regulations and exacting demands of the biopharmaceutical industry.

From KNAUER Wissenschaftliche Geräte GmbH 14 Oct 2021

COVID-19 linked to newborn complications

A recent study discusses whether pregnant women with the COVID-19 are at a higher risk for poor outcomes for themselves and their babies.

13 Oct 2021

Small portion of COVID-19 patients infectious long-term

In late December 2019, a novel pneumonia-like lung infection was reported in the Chinese province of Hubei. This, in turn, led to the ongoing coronavirus disease-19 (COVID-19) pandemic. COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is closely related to SARS (Severe Acute Respiratory Syndrome) and MERS (the Middle East Respiratory Syndrome Coronavirus).

13 Oct 2021

Instability in gut microbiota associated with COVID-19-related complications and mortality, study finds

Researchers from Germany recently analyzed saliva and fecal samples from SARS-CoV-2 infected and post-COVID-19 patients and controls while considering multiple influencing factors during hospitalization. This study is available on the bioRxiv* preprint server.

13 Oct 2021

Anti-rheumatic drug as a potential candidate for treating COVID-19

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) produces inflammatory cytokine storms. But an FDA-approved anti-rheumatic drug, Auranofin, used to treat autoimmune and infectious diseases, may also help serve as an antiviral treatment for COVID-19 infection.

13 Oct 2021

Role of CRISPR-Cas12a visual biosensor in detection of SARS-CoV-2

A new study aimed to develop a novel CRISPR-Cas12a powered visual biosensor for the detection of SARS-CoV-2.

13 Oct 2021

New method to diagnose anosmia

In a recent study, researchers discuss a new method of tracking the Nav1.7 channel to reduce the reliance on more invasive diagnostic measures.

13 Oct 2021

New high-throughput assay could help development of anti-COVID-19 drugs

In a recent study, researchers develop a new high-throughput assay that allows for rapid screening of potential inhibitors.

13 Oct 2021

Poor timing of flu vaccinations associated with poor birth outcomes and cesarean births

With flu season approaching in the United States, new research from an international team of scientists testifies to the importance of timely vaccination: Poor timing of influenza vaccination campaigns in the semi-arid region of Brazil led to an increase in premature births, lower birth-weight babies and the need to deliver more babies by cesarean section, the researchers found.

13 Oct 2021

Pandemic News and Research

Further Reading

SARS-CoV-2 induces tissue immune memory

COVID-19 immunity in family members reduces risk of infection by 45-97%

Mutation of cysteine residues in NRP1 reduces SARS-CoV-2 spike protein entry into cells

Improving COVID-19 vaccinations through contact-tracing apps

Study finds relatively low rate of COVID-19 infection following full vaccination in North Carolina

Ondansetron use associated with increased survival in mechanically ventilated COVID-19 patients

Methods used to limit transmission of SARS-CoV-2 effective against other viruses in China

COVID-19 booster for immunosuppressed patients with inflammatory bowel disease

Developing New Technology for the Encapsulation of mRNA-Based Vaccines in Lipid Nanoparticles (LNPs)

COVID-19 linked to newborn complications

Small portion of COVID-19 patients infectious long-term

Instability in gut microbiota associated with COVID-19-related complications and mortality, study finds

Anti-rheumatic drug as a potential candidate for treating COVID-19

Role of CRISPR-Cas12a visual biosensor in detection of SARS-CoV-2

New method to diagnose anosmia

New high-throughput assay could help development of anti-COVID-19 drugs

Poor timing of flu vaccinations associated with poor birth outcomes and cesarean births

The relationship between COVID-19 certification and vaccine uptake

COVID-19 vaccination induces transient increase in cellular and antibody responses to S1 antigenic sequence

Study uncovers encouraging news for rural and remote stroke patients in Australia

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News